ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 7c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS